272 related articles for article (PubMed ID: 28004395)
1. Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.
Nelson MD; Sharif B; Shaw JL; Cook-Wiens G; Wei J; Shufelt C; Mehta PK; Thomson LEJ; Berman DS; Thompson RB; Handberg EM; Pepine CJ; Li D; Bairey Merz CN
Clin Cardiol; 2017 May; 40(5):300-306. PubMed ID: 28004395
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.
Shah NR; Cheezum MK; Veeranna V; Horgan SJ; Taqueti VR; Murthy VL; Foster C; Hainer J; Daniels KM; Rivero J; Shah AM; Stone PH; Morrow DA; Steigner ML; Dorbala S; Blankstein R; Di Carli MF
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473401
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
Bairey Merz CN; Handberg EM; Shufelt CL; Mehta PK; Minissian MB; Wei J; Thomson LE; Berman DS; Shaw LJ; Petersen JW; Brown GH; Anderson RD; Shuster JJ; Cook-Wiens G; Rogatko A; Pepine CJ
Eur Heart J; 2016 May; 37(19):1504-13. PubMed ID: 26614823
[TBL] [Abstract][Full Text] [Related]
4. Relationship between coronary microvascular dysfunction (CMD) and left ventricular diastolic function in patients with symptoms of myocardial ischemia with non-obstructive coronary artery disease (INOCA) by cardiovascular magnetic resonance feature-tracking.
Kong H; Cao J; Tian J; Yong J; An J; Song X; He Y
Clin Radiol; 2024 Jul; 79(7):536-543. PubMed ID: 38679491
[TBL] [Abstract][Full Text] [Related]
5. Effects of ranolazine on left ventricular diastolic and systolic function in patients with chronic coronary disease and stable angina.
Babalis D; Tritakis V; Floros G; Mouzarou A; Kafkas N; Bampali K; Mertzanos G
Hellenic J Cardiol; 2015; 56(3):237-41. PubMed ID: 26021246
[TBL] [Abstract][Full Text] [Related]
6. Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.
Wei J; Nelson MD; Szczepaniak EW; Smith L; Mehta PK; Thomson LE; Berman DS; Li D; Bairey Merz CN; Szczepaniak LS
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H14-9. PubMed ID: 26519031
[TBL] [Abstract][Full Text] [Related]
7. Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
Rambarat CA; Elgendy IY; Handberg EM; Bairey Merz CN; Wei J; Minissian MB; Nelson MD; Thomson LEJ; Berman DS; Shaw LJ; Cook-Wiens G; Pepine CJ
Int J Cardiol; 2019 Feb; 276():8-13. PubMed ID: 30293664
[TBL] [Abstract][Full Text] [Related]
8. Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial.
Schwemer TF; Radziwolek L; Deutscher N; Diermann N; Sehner S; Blankenberg S; Friedrich FW
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):62-69. PubMed ID: 29938533
[TBL] [Abstract][Full Text] [Related]
9. Diastolic dysfunction measured by cardiac magnetic resonance imaging in women with signs and symptoms of ischemia but no obstructive coronary artery disease.
Wei J; Mehta PK; Shufelt C; Yang Y; Gill E; Kahlon R; Cook-Wiens G; Minissian M; Kar S; Thomson L; Berman D; Merz CN
Int J Cardiol; 2016 Oct; 220():775-80. PubMed ID: 27394973
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
Tamarappoo B; Samuel TJ; Elboudwarej O; Thomson LEJ; Aldiwani H; Wei J; Mehta P; Cheng S; Sharif B; AlBadri A; Handberg EM; Petersen J; Pepine CJ; Nelson MD; Bairey Merz CN
Int J Cardiol; 2021 Mar; 327():25-30. PubMed ID: 33202262
[TBL] [Abstract][Full Text] [Related]
12. Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate.
Golino M; Spera FR; Manfredonia L; De Vita A; Di Franco A; Lamendola P; Villano A; Melita V; Mencarelli E; Lanza GA; Crea F
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6545-6550. PubMed ID: 30338825
[TBL] [Abstract][Full Text] [Related]
13. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Mehta PK; Goykhman P; Thomson LE; Shufelt C; Wei J; Yang Y; Gill E; Minissian M; Shaw LJ; Slomka PJ; Slivka M; Berman DS; Bairey Merz CN
JACC Cardiovasc Imaging; 2011 May; 4(5):514-22. PubMed ID: 21565740
[TBL] [Abstract][Full Text] [Related]
15. Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study.
Kumarathurai P; Sajadieh A; Anholm C; Kristiansen OP; Haugaard SB; Nielsen OW
Cardiovasc Diabetol; 2021 Jan; 20(1):12. PubMed ID: 33413428
[TBL] [Abstract][Full Text] [Related]
16. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death.
Hong D; Lee SH; Shin D; Choi KH; Kim HK; Ha SJ; Joh HS; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Lee JM
J Am Heart Assoc; 2023 Feb; 12(3):e027690. PubMed ID: 36695307
[TBL] [Abstract][Full Text] [Related]
18. Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening.
Sorop O; Heinonen I; van Kranenburg M; van de Wouw J; de Beer VJ; Nguyen ITN; Octavia Y; van Duin RWB; Stam K; van Geuns RJ; Wielopolski PA; Krestin GP; van den Meiracker AH; Verjans R; van Bilsen M; Danser AHJ; Paulus WJ; Cheng C; Linke WA; Joles JA; Verhaar MC; van der Velden J; Merkus D; Duncker DJ
Cardiovasc Res; 2018 Jun; 114(7):954-964. PubMed ID: 29432575
[TBL] [Abstract][Full Text] [Related]
19. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease.
Michelsen MM; Pena A; Mygind ND; Bech J; Gustafsson I; Kastrup J; Hansen HS; Høst N; Hansen PR; Prescott E
Echocardiography; 2018 Feb; 35(2):196-203. PubMed ID: 29222822
[TBL] [Abstract][Full Text] [Related]
20. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
